Procainamide was prescribed for a patient who has ventricular tachycardia. Which adverse actions of this medication should the nurse explain to the patient? (Select all that apply.)
a. Anorexia
b. Hypotension
c. Flushness in the face
d. Cool hands
e. Headache
ANS: A, B
Procainamide may cause anorexia and severe hypotension.
You might also like to view...
A patient will be undergoing abdominal computed tomography (CT) with contrast. The nurse has administered IV sodium bicarbonate and oral acetylcysteine (Mucomyst) before the study as ordered
What would indicate that these medications have had the desired therapeutic effect? A) The patient's BUN and creatinine levels are within reference range following the CT. B) The CT yields high-quality images. C) The patient's electrolytes are stable in the 48 hours following the CT. D) The patient's intake and output are in balance on the day after the CT.
A patient is 24 hours postoperative following prostatectomy and the urologist has ordered continuous bladder irrigation. What color of output should the nurse expect to find in the drainage bag?
A) Red wine colored B) Tea colored C) Amber D) Light pink
The nurse is reviewing care of clients on a mother-baby unit. Which situation should be reported to the supervisor?
1. A 2-day-old infant has breastfed every 3 hours and voided four times. 2. An infant was placed in the wrong crib after examination by the physician. 3. The client who delivered by cesarean birth yesterday received oral narcotics. 4. A primiparous client who delivered today is requesting discharge within 24 hours.
While reading the package insert that accompanies a medication, you note that it has been assigned a pregnancy category D. This means that:
A. studies in animals have demonstrated adverse effects; however, studies have not been conducted in humans. B. studies in animals have not demonstrated a risk to the fetus; however, adequate studies have not been performed in humans. C. risk of adverse effects has clearly been demonstrated in humans; therefore, the drug should not be administered to pregnant women. D. risk to the human fetus has been demonstrated; however, administration of the drug may outweigh the risk of potential adverse effects in certain circumstances.